Diabetes-Lancets

Diabetes In Control.com

Contact: Steve Freed, R.Ph. Publisher                                        Tel. 800-798-6972 Cell: 312-343-7773
Email: publisher@diabetesincontrol.com
http://web.archive.org/web/20071018151058/http://www.diabetesincontrol.com/

On Dec 4, 2002, Diabetes In Control.com, a free newsletter for medical professionals in diabetes care will be releasing a 3-part feature article:

INSULIN INJECTIONS, NO MORE! …STOPPING THE DIABETES PANDEMIC

New Treatment Will Be Good News to 150 Million Worldwide, Including 15 Million Children

Researchers at two nationally known universities report they’re closing in on a new treatment, possibly even a cure for certain common types of diabetes. Dr. Aaron Vink at EVMS, one of the lead researchers stated that, “We saw a reversal of diabetes when the compound was administered at an adequate dose and for a sufficient period of time.” The research at, Eastern Virginia Medical School and McGill University in Montreal and financially supported by the Procter and Gamble Company is working to develop a new treatment for Type 1 and Type 2 diabetes. If successful, it could eliminate the need for insulin injections forever.

It could be a cure type 1 diabetes, which effects over a million and a half people in the US. It could also affect the lives of over 6 million people in the US who have type 2 diabetes and must inject daily insulin to survive.

The treatment is now in phase one trials at four sites and expects to go to Phase 2 trials next year. If successful, it will have a dramatic effect on the US and global economy. Diabetes is a 100 billion dollar industry in just the US (27% of the Medicare Budget). It can change the quality of lives and longevity for millions of people with diabetes.

·    Diabetes is the leading cause of blindness and kidney failure.

·    It can quadruple the risk of heart disease and stroke

·    Each year a million people are diagnosed with diabetes and over 400,000 die from it

·    Diabetes has increased 70% for people in their 30’s

·    Causes over 90.0000 amputations a year

·    The Diabetes Epidemic is expected to double in 25 years

On Dec 4th, Diabetes In Control, a free weekly newsletter for medical professionals, will be starting a 3-part feature on the development and current research trials for this new treatment beginning. If you have or know someone with diabetes, make sure they are aware of this research, they could be eligible for participation in the trials. For more information or to subscribe to the free newsletter go to
http://web.archive.org/web/20071018151058/http://www.diabetesincontrol.com/

This article courtesy of http://web.archive.org/web/20071018151058/http://www.diabetes-lancets.com/.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and URL remain intact.

*************************************************

SHOPPING FOR MORE THAN JUST DIABETIC LANCETS?

We recommend The Diabetic Supplies Review that covers the best online suppliers for the insured and the uninsured diabetic.

*************************************************

The American Diabetes Association endorses the statement that:

A Diagnosis of Peripheral Arterial Disease (PAD) is Important for People with Diabetes

The Vascular Disease Foundation added its own endorsement  to the recommendations for treating PAD in the individual with diabetes. A consensus statement was published with the American Diabetes Association (ADA) in the December 2003 issue of Diabetes Care. Currently, there are no specific guidelines for care for physicians treating the patient with both diseases.

PAD is a serious, vascular complication in people with diabetes that often goes undetected and under-treated. PAD has few symptoms, and affects one of three with diabetes over age 50,  increasing the potential for disability and amputation. There is also a higher risk of heart attack and stroke associated with PAD combined with diabetes, than with PAD alone.

This  published statement is a result of a Consensus Development Conference organized by the ADA last spring. They identified several differences in how PAD affects the arteries of people with diabetes compared to those with PAD only.  Vascular Disease Foundation Director, Dr. Judy Regensteiner, was a member of the Panel that developed this Consensus Statement. To see the entire report, click this link to the report.

Or, call the ADA at 1-800-DIABETES (1-800-342-2383).

Key recommendations from the ADA Consensus Panel were:

·   People over the age of 50 who have diabetes should be screened for PAD. People with diabetes who are younger than 50 should be considered for screening if they have other risk factors for this condition, including smoking, high blood pressure, high cholesterol or having diabetes for more than 10 years.

·   The recommended test for PAD is the ankle brachial index (ABI). If results are normal, it should be repeated every 5 years.